Fact CheckerSign in

NCT06231810Recruiting

Tracking a Tactile Signal Along the Nervous System

Source: ClinicalTrials.gov · Last updated 17 Jun 2026

Brief summary (registry, in English)

Quantify the flow of a tactile signal from the stimulus at the finger at the peripheral nervous system (PNS), to the central nervous system (CNS), and to cognitive perception at the brain in young adults (Aim 1) and individuals with and without stroke (Aim 2).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
8 Jan 2024
Start date
29 Feb 2024
Primary completion date
1 Jul 2027
Lead sponsor
Virginia Polytechnic Institute and State University
Diseases
Stroke
NCT number
NCT06231810

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 29 Feb 2024 to the primary completion date, 1 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • participants with stroke who have used antispastic injections in the past six months
  • participants with stroke who have a lesion in the brainstem and/or cerebellum
  • participants with stroke who have a stroke arising due to brain surgery
  • participants with stroke who have hemineglect

Other

  • minors
  • pregnant women
  • prisoners
  • adults not capable of consenting on their own behalf.
    • For Aim 2:

Who the study is looking for

  • -right-hand dominance for participants who are neurotypical
  • For Aim 1:
  • -age range of 18-23
  • For Aim 2:
  • participants who are neurotypical will be a similar age to the participants with stroke
  • participants who are neurotypical will have no musculoskeletal and neurological conditions
  • participants with stroke will have a single stroke incident resulting in a unilateral lesion (ischemic and hemorrhagic)
  • participants with stroke will be in the chronic phase (\>1 year from stroke onset)
  • participants with stroke will have an onset of stroke after the age of 18
  • participants with stroke who meet the criteria of having the capacity to provide informed consent, regardless of aphasia

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Virginia Tech
Coordinator of this site? Confirm its status
BlacksburgUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.